Fulgent Genetics Inc
FLGT18.242USD
-0.288-1.55%
交易中 （美东）报价延迟15分钟
558.35M总市值
亏损市盈率 TTM
关于 Fulgent Genetics Inc 公司
Fulgent Genetics, Inc. 是一家技术型基因公司，拥有实验室服务业务和治疗开发业务。该公司的实验室服务业务包括技术实验室服务和执业医师对实验室结果的专业解释。其治疗开发业务专注于使用纳米封装和靶向治疗平台开发用于治疗一系列癌症的候选药物，旨在改善新旧抗癌药物的治疗窗口和药代动力学 (PK) 特征。其实验室服务业务的技术平台包括基因探针、数据抑制和比较算法、学习软件和实验室信息管理系统。该平台提供测试菜单、快速开发和启动新测试的能力以及可定制的测试产品。该公司还提供下一代测序 (NGS) 服务。
公司简介
公司代码FLGT
公司名称Fulgent Genetics Inc
上市日期Sep 28, 2016
CEOMr. Ming Hsieh
员工数量1313
证券类型Ordinary Share
年结日Sep 28
公司地址4399 Santa Anita Ave
城市EL MONTE
上市交易所NASDAQ Global Market Consolidated
国家United States of America
邮编91731
电话16263500537
网址https://www.fulgentgenetics.com/
公司代码FLGT
上市日期Sep 28, 2016
CEOMr. Ming Hsieh
公司高管
名称
名称/职务
职务
持股
持股变动
Mr. Ming Hsieh
Mr. Ming Hsieh
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
8.77M
-0.07%
Dr. Hanlin (Harry) Gao, M.D., Ph.D.
Dr. Hanlin (Harry) Gao, M.D., Ph.D.
Chief Scientific Officer, Laboratory Director
Chief Scientific Officer, Laboratory Director
876.30K
-0.19%
Mr. Jian (James) Xie
Mr. Jian (James) Xie
President, Chief Operating Officer
President, Chief Operating Officer
243.59K
-1.76%
Mr. Paul Kim, CPA
Mr. Paul Kim, CPA
Chief Financial Officer
Chief Financial Officer
237.31K
-1.14%
Ms. Linda Marsh
Ms. Linda Marsh
Independent Director
Independent Director
18.11K
+98.39%
Ms. Regina E. (Reggie) Groves
Ms. Regina E. (Reggie) Groves
Independent Director
Independent Director
12.23K
+276.37%
Dr. Michael Nohaile, Ph.D.
Dr. Michael Nohaile, Ph.D.
Independent Director
Independent Director
10.51K
+74.68%
Ms. Melanie Solomon
Ms. Melanie Solomon
Investor Relations
Investor Relations
--
--
名称
名称/职务
职务
持股
持股变动
Mr. Ming Hsieh
Mr. Ming Hsieh
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
8.77M
-0.07%
Dr. Hanlin (Harry) Gao, M.D., Ph.D.
Dr. Hanlin (Harry) Gao, M.D., Ph.D.
Chief Scientific Officer, Laboratory Director
Chief Scientific Officer, Laboratory Director
876.30K
-0.19%
Mr. Jian (James) Xie
Mr. Jian (James) Xie
President, Chief Operating Officer
President, Chief Operating Officer
243.59K
-1.76%
Mr. Paul Kim, CPA
Mr. Paul Kim, CPA
Chief Financial Officer
Chief Financial Officer
237.31K
-1.14%
Ms. Linda Marsh
Ms. Linda Marsh
Independent Director
Independent Director
18.11K
+98.39%
Ms. Regina E. (Reggie) Groves
Ms. Regina E. (Reggie) Groves
Independent Director
Independent Director
12.23K
+276.37%
收入明细
单位: USD更新时间: 7月6日 周日
单位: USD更新时间: 7月6日 周日
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
业务USD
名称
营收
占比
Insurance
41.32M
56.25%
Institutional
30.74M
41.85%
Patient
1.40M
1.90%
地区USD
名称
营收
占比
United States
67.83M
92.33%
Foreign
5.64M
7.67%
业务
地区
业务USD
名称
营收
占比
Insurance
41.32M
56.25%
Institutional
30.74M
41.85%
Patient
1.40M
1.90%
股东统计
更新时间: 5月17日 周六
更新时间: 5月17日 周六
持股股东
股东类型
持股股东
持股股东
占比
Hsieh (Ming)
28.80%
BlackRock Institutional Trust Company, N.A.
5.55%
Millennium Management LLC
4.74%
The Vanguard Group, Inc.
3.83%
Dimensional Fund Advisors, L.P.
3.38%
Other
53.70%
持股股东
持股股东
占比
Hsieh (Ming)
28.80%
BlackRock Institutional Trust Company, N.A.
5.55%
Millennium Management LLC
4.74%
The Vanguard Group, Inc.
3.83%
Dimensional Fund Advisors, L.P.
3.38%
Other
53.70%
股东类型
持股股东
占比
Individual Investor
33.39%
Investment Advisor/Hedge Fund
17.42%
Investment Advisor
17.28%
Hedge Fund
16.03%
Research Firm
3.25%
Bank and Trust
0.45%
Pension Fund
0.26%
Venture Capital
0.06%
Insurance Company
0.02%
Other
11.83%
机构持股
更新时间: 7月1日 周二
更新时间: 7月1日 周二
报告期
机构数
持股数
持股占比
持股变动
2025Q2
462
26.90M
88.35%
-2.94M
2025Q1
479
26.79M
87.53%
-3.17M
2024Q4
478
27.37M
89.05%
-1.51M
2024Q3
495
26.29M
86.76%
-1.76M
2024Q2
531
25.43M
84.95%
-2.34M
2024Q1
552
25.03M
83.71%
-1.71M
2023Q4
583
24.11M
81.35%
-2.57M
2023Q3
588
24.06M
80.39%
-2.54M
2023Q2
592
23.63M
79.58%
-3.71M
2023Q1
620
23.53M
79.25%
-3.02M
查看更多
股东持股明细
名称
持股数
占比
持股变动
变动比例
公告日期
Hsieh (Ming)
8.77M
28.8%
-6.40K
-0.07%
May 26, 2025
BlackRock Institutional Trust Company, N.A.
1.69M
5.55%
-1.55M
-47.88%
Mar 31, 2025
Millennium Management LLC
1.97M
6.47%
+437.63K
+28.57%
Mar 31, 2025
The Vanguard Group, Inc.
1.16M
3.83%
-223.10K
-16.07%
Mar 31, 2025
Dimensional Fund Advisors, L.P.
1.03M
3.38%
-16.82K
-1.61%
Mar 31, 2025
Gao (Hanlin)
877.95K
2.88%
-754.00
-0.09%
Jun 02, 2025
Acadian Asset Management LLC
805.94K
2.65%
+446.08K
+123.96%
Mar 31, 2025
Columbia Threadneedle Investments (US)
625.30K
2.05%
+123.49K
+24.61%
Mar 31, 2025
State Street Global Advisors (US)
506.79K
1.66%
-312.64K
-38.15%
Mar 31, 2025
Geode Capital Management, L.L.C.
505.24K
1.66%
-8.91K
-1.73%
Mar 31, 2025
查看更多
持股ETF
更新时间: 8月2日 周六
更新时间: 8月2日 周六
机构名称
占比
SPDR S&P Health Care Services ETF
0.84%
Global X Genomics & Biotechnology ETF
0.51%
ALPS Medical Breakthroughs ETF
0.41%
iShares US Small Cap Value Factor ETF
0.28%
iShares MSCI USA Small-Cap Min Vol Factor ETF
0.07%
JPMorgan Diversified Return U.S. Small Cap Equity ETF
0.06%
iShares U.S. Healthcare Providers ETF
0.06%
Invesco RAFI US 1500 Small-Mid ETF
0.05%
Avantis US Small Cap Equity ETF
0.05%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
0.05%
查看更多
SPDR S&P Health Care Services ETF
占比0.84%
Global X Genomics & Biotechnology ETF
占比0.51%
ALPS Medical Breakthroughs ETF
占比0.41%
iShares US Small Cap Value Factor ETF
占比0.28%
iShares MSCI USA Small-Cap Min Vol Factor ETF
占比0.07%
JPMorgan Diversified Return U.S. Small Cap Equity ETF
占比0.06%
iShares U.S. Healthcare Providers ETF
占比0.06%
Invesco RAFI US 1500 Small-Mid ETF
占比0.05%
Avantis US Small Cap Equity ETF
占比0.05%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
占比0.05%
分红派息
近5年累计派现
0.00
美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据
拆合股
公告日期
类型
比率
暂无数据
公告日期
类型
比率
暂无数据
